Nitroglycerin chemical structure

Acrux scores fourth FDA approval, Nitroglycerin Ointment moving into commercialisation

Acrux Ltd has achieved the fourth approval from the US FDA, with its Nitroglycerin Ointment 0.4%,…
Image of a baby's brain

FDA awards Argenica two key designations for drug candidate targeting infant brain injury

Argenica Therapeutics Ltd has received two key designations from the US Food and Drug Administration for…
Mesoblast (ASX:MSB) - CEO & Managing Director, Silviu Itescu

Cashed up & ready to go: Mesoblast forges funding deal with top shareholder

Mesoblast (ASX:MSB) is trading up more than 1.75% after striking a funding deal with its largest…
Image of Autoimmune Myocarditis Heart Muscle Inflammation

EBR reaches review milestone for wireless cardiac pacing device

EBR Systems Inc has reached an important stage in its progress to commercialise its WiSE CRT…
Dale Gillham's photo, and wording 'Words from Wealth Within's Chief Analyst Dale Gillham.

Dale Gillham’s weekly wrap: Will FDA tick give Mesoblast a boost?

The sellers finally stepped in this week to push the All Ordinaries Index down more than…